Reviewing Swisscom (SCMWY) and Its Competitors

Swisscom (OTCMKTS: SCMWY) is one of 41 public companies in the “UTIL-TELEPHONE” industry, but how does it weigh in compared to its rivals? We will compare Swisscom to related businesses based on the strength of its analyst recommendations, profitability, valuation, risk, institutional ownership, earnings and dividends.

Valuation and Earnings

How to Become a New Pot Stock Millionaire

This table compares Swisscom and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Swisscom $11.85 billion $1.60 billion 15.96
Swisscom Competitors $13.90 billion $1.18 billion 3.29

Swisscom’s rivals have higher revenue, but lower earnings than Swisscom. Swisscom is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

0.1% of Swisscom shares are owned by institutional investors. Comparatively, 41.4% of shares of all “UTIL-TELEPHONE” companies are owned by institutional investors. 1.0% of Swisscom shares are owned by company insiders. Comparatively, 8.1% of shares of all “UTIL-TELEPHONE” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Dividends

Swisscom pays an annual dividend of $1.83 per share and has a dividend yield of 3.7%. Swisscom pays out 59.2% of its earnings in the form of a dividend. As a group, “UTIL-TELEPHONE” companies pay a dividend yield of 4.6% and pay out 1,608.2% of their earnings in the form of a dividend.

Volatility & Risk

Swisscom has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Swisscom’s rivals have a beta of 0.59, indicating that their average stock price is 41% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Swisscom and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Swisscom 1 1 1 0 2.00
Swisscom Competitors 365 914 944 43 2.29

As a group, “UTIL-TELEPHONE” companies have a potential upside of 172.87%. Given Swisscom’s rivals stronger consensus rating and higher possible upside, analysts plainly believe Swisscom has less favorable growth aspects than its rivals.

Profitability

This table compares Swisscom and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Swisscom 13.47% 22.88% 7.26%
Swisscom Competitors 8.48% 4.23% 3.78%

Summary

Swisscom rivals beat Swisscom on 9 of the 15 factors compared.

About Swisscom

Swisscom AG is a holding company. The Company, through its subsidiaries, provides telecommunication services in Switzerland and Italy. The Company’s segments include Swisscom Switzerland, Fastweb, Other Operating Segments and Group Headquarters. Swisscom Switzerland comprises the customer segments, Residential Customers, Enterprise Customers and Wholesale, as well as the information technology (IT), Network and Infrastructure division. Fastweb is an alternative service provider in the Italian fixed-network market for both residential and business customers. The Other Operating Segments includes the Digital Business unit, as well as Participations and Subsidiaries in the areas of payment solutions, network construction and maintenance, radio transmitters, energy management and event solutions. Group Headquarters includes Group Business Steering, Group Strategy and Board Services, Group Communications and Responsibility, Group Security, Group Human Resources and Worklink AG.

Receive News & Ratings for Swisscom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swisscom and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Perrigo  Given a $105.00 Price Target by Canaccord Genuity Analysts
Perrigo Given a $105.00 Price Target by Canaccord Genuity Analysts
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics Stock Price
FTD Companies  Getting Somewhat Positive Press Coverage, Report Shows
FTD Companies Getting Somewhat Positive Press Coverage, Report Shows
Koovs  Stock Price Up 28.2%
Koovs Stock Price Up 28.2%
Rigel Pharmaceuticals   Shares Down 6.5%
Rigel Pharmaceuticals Shares Down 6.5%
Dicerna Pharmaceuticals  Shares Up -6.6%
Dicerna Pharmaceuticals Shares Up -6.6%


© 2006-2018 Ticker Report. Google+.